The FDA solicited comments on these requirements in the notice of proposed rulemaking and has evaluated and responded to them in the preamble to the final rule.
( ( The ( FDA solicited ) ) ( ( ( ( ( comments ( on ( these requirements ) ) ) ( in ( ( the notice ) ( of ( proposed rulemaking ) ) ) ) ) and ) ( has ( ( ( ( ( evaluated and ) responded ) ( to them ) ) ( in ( the preamble ) ) ) ( to ( the ( final rule ) ) ) ) ) ) . ) )
(ROOT (S (NP (DT The) (NNP FDA) (NNP solicited)) (VP (VP (VBZ comments) (PP (IN on) (NP (DT these) (NNS requirements))) (PP (IN in) (NP (NP (DT the) (NN notice)) (PP (IN of) (NP (VBN proposed) (NN rulemaking)))))) (CC and) (VP (VBZ has) (VP (VBN evaluated) (CC and) (VBN responded) (PP (TO to) (NP (PRP them))) (PP (IN in) (NP (DT the) (NN preamble))) (PP (TO to) (NP (DT the) (JJ final) (NN rule)))))) (. .)))
The FTA had sought out comments on these requirements relating to the proposed rulemaking.
( ( The FTA ) ( ( had ( ( ( sought out ) ( comments ( on ( these requirements ) ) ) ) ( relating ( to ( the ( proposed rulemaking ) ) ) ) ) ) . ) )
(ROOT (S (NP (DT The) (NNP FTA)) (VP (VBD had) (VP (VBN sought) (PRT (RP out)) (NP (NP (NNS comments)) (PP (IN on) (NP (DT these) (NNS requirements)))) (S (VP (VBG relating) (PP (TO to) (NP (DT the) (VBN proposed) (NN rulemaking))))))) (. .)))